COPD clinical trial: Mid Yorkshire Teaching NHS Trust recruits first patient to new COPD clinical trial
Mid Yorkshire Teaching NHS Trust has become the first site in Europe to recruit a patient to a major international clinical trial investigating a potential new treatment for chronic obstructive pulmonary disease (COPD).
The study is examining certain treatments that can safely reduce flare-ups and improve quality of life for people living with moderate to very severe COPD and has been part of the Commercial Research Delivery Centre partnership (CRDC).
The project is a large clinical trial taking place across the world, involving around 990 participants.
Patients who take part will receive treatments every four weeks for up to 98 weeks, with regular clinic visits and questionnaires to monitor their progress.
This new regional hub brings together partners to collaborate and deliver services across the region.
Deputy Director of Research at Mid Yorkshire Teaching NHS Trust Judith Holliday, said: “Recruiting the first European patient to this important COPD trial is a fantastic achievement for our research team.
"It demonstrates our commitment to bringing cutting-edge treatments to patients in Mid Yorkshire and contributing to global efforts to improve care for people living with chronic conditions.
"We’re proud to play a role in advancing research that could make a real difference to quality of life for those affected by COPD.”
People aged 40–80 with COPD who are current or former smokers and have been on the same inhaler for at least three months may be eligible to take part.
To find out more about taking part in research, visit Be Part of Research.